Robert John Mentz, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member in the Duke Clinical Research Institute
Campus mail Np-8062, Dcri. PO Box 17969, Durham, NC 27715
Phone (919) 668-7121
Email address robert.mentz@duke.edu

I am a cardiologist with a clinical and research interest in heart failure, including advanced therapies such as cardiac transplantation and mechanical assist devices or “heart pumps." I became a heart failure cardiologist in order to help patients manage their chronic disease over many months and years. I consider myself strongly committed to compassionate patient care with a focus on quality of life and patient preference.

My research interests are focused on treating co-morbid diseases in heart failure patients and improving outcomes across the cardiovascular spectrum through clinical trials and outcomes research. Below, you will find my specific research interests:

  •     Co-morbidity characterization (diabetes, sleep apnea, renal failure) in heart failure.
  •     Phenotypic characterization and risk prognostication of patients with heart failure.
  •     Role of surrogate and nonfatal endpoints in clinical heart failure trials.
  •     Biomarkers in heart failure.
  •     Novel pharmacological and non-pharmacological approaches to heart failure.
  •     Improving site-based heart failure research.
In Their Words

Education and Training

  • Fellowship, Advanced Heart Failure, Duke University School of Medicine, 2012 - 2013
  • Fellowship, Clinical Cardiology, Duke University School of Medicine, 2010 - 2012
  • Resident, Internal Medicine, Brigham and Women's Hospital, 2008 - 2010
  • Intern, Internal Medicine, Brigham and Women's Hospital, 2007 - 2008
  • M.D., Emory University, 2003

Publications

Shah, Ravi V., Aferdita Spahillari, Stanford Mwasongwe, J Jeffrey Carr, James G. Terry, Robert J. Mentz, Daniel Addison, et al. “Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study..” Jama Cardiol 2, no. 6 (June 1, 2017): 644–52. https://doi.org/10.1001/jamacardio.2017.0944.

PMID
28315622
Full Text

Selvaraj, Senthil, Sanjiv J. Shah, Mark J. Ommerborn, Cheryl R. Clark, Michael E. Hall, Robert J. Mentz, Saadia Qazi, et al. “Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study..” Circ Heart Fail 10, no. 6 (June 2017). https://doi.org/10.1161/CIRCHEARTFAILURE.116.003940.

PMID
28611127
Full Text

Bhatt, Ankeet S., Adam D. DeVore, Tracy A. DeWald, Karl Swedberg, and Robert J. Mentz. “Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?.” J Am Coll Cardiol 69, no. 20 (May 23, 2017): 2542–50. https://doi.org/10.1016/j.jacc.2017.03.563.

PMID
28521892
Full Text

Mentz, Robert J., M Angelyn Bethel, Stephanie Gustavson, Vivian P. Thompson, Neha J. Pagidipati, John B. Buse, Juliana C. Chan, et al. “Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)..” Am Heart J 187 (May 2017): 1–9. https://doi.org/10.1016/j.ahj.2017.02.005.

PMID
28454792
Full Text

Zsilinszka, Reka, Robert J. Mentz, Adam D. DeVore, Zubin J. Eapen, Peter S. Pang, and Adrian F. Hernandez. “Acute Heart Failure: Alternatives to Hospitalization..” Jacc Heart Fail 5, no. 5 (May 2017): 329–36. https://doi.org/10.1016/j.jchf.2016.12.014.

PMID
28285117
Full Text

Zakeri, Rosita, David R. Van Wagoner, Hugh Calkins, Tom Wong, Heather M. Ross, E Kevin Heist, Timothy E. Meyer, et al. “The burden of proof: The current state of atrial fibrillation prevention and treatment trials..” Heart Rhythm 14, no. 5 (May 2017): 763–82. https://doi.org/10.1016/j.hrthm.2017.01.032.

PMID
28161513
Full Text

Dunlay, Shannon M., Steven J. Lippmann, Melissa A. Greiner, Emily C. O’Brien, Alanna M. Chamberlain, Robert J. Mentz, and Mario Sims. “Perceived Discrimination and Cardiovascular Outcomes in Older African Americans: Insights From the Jackson Heart Study..” Mayo Clin Proc 92, no. 5 (May 2017): 699–709. https://doi.org/10.1016/j.mayocp.2017.01.024.

PMID
28473034
Full Text

Luo, Nancy, Peter Merrill, Kishan S. Parikh, David J. Whellan, Ileana L. Piña, Mona Fiuzat, William E. Kraus, et al. “Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation..” J Am Coll Cardiol 69, no. 13 (April 4, 2017): 1683–91. https://doi.org/10.1016/j.jacc.2017.01.032.

PMID
28359513
Full Text

Ambrosy, Andrew P., Lukasz P. Cerbin, Adam D. DeVore, Stephen J. Greene, William E. Kraus, Christopher M. O’Connor, Ileana L. Piña, et al. “Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial..” Am Heart J 186 (April 2017): 130–38. https://doi.org/10.1016/j.ahj.2016.12.017.

PMID
28454828
Full Text

Luo, Nancy, Gregg C. Fonarow, Steven J. Lippmann, Xiaojuan Mi, Paul A. Heidenreich, Clyde W. Yancy, Melissa A. Greiner, et al. “Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF)..” Jacc Heart Fail 5, no. 4 (April 2017): 305–9. https://doi.org/10.1016/j.jchf.2016.12.018.

PMID
28359417
Full Text

Pages